|
⚲
|
| Tarsa Therapeutics Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001475030 |
| Sale | 2009-10-19 ($24.1 M Offered, $12.1 M Sold) |
| Fund | |
| Phone | 6173832101 |
| Address | 45 School Street Boston, 02108 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| David Brand | |
| Eric Bednarski |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Skaff Raymond
✚
|
0.0 | |
|
Skai, Inc.
✚
|
0.0 | |
|
Skalko Tammy L
✚
|
0.0 | |
|
AEA Growth Equity Fund LP
✚
|
0.0 | |
|
AE VV RGV Portfolio MF LP
✚
|
0.0 | |
|
Root Health, LLC
✚
|
0.0 | |
|
SRG Max Wells Panning Joint Venture
✚
|
0.0 | |
|
Sri - SLF III LP
✚
|
0.0 | |
|
Stirling Square Capital Partners Third Fund A Limited Partne
✚
|
0.0 | |
|
SIXT Austin, LLC
✚
|
0.0 |